GenScript and Tamarind Bio have formed a strategic partnership to connect Tamarind Bio's AI-powered molecular design platform with GenScript's wet-lab validation capabilities, creating a "connected validation engine" for AI-enabled drug discovery.
Researchers using Tamarind Bio's platform can now submit AI-generated sequences directly to GenScript for end-to-end services, including gene synthesis, protein expression, and functional testing, streamlining the path from digital designs to experimental proof.
The collaboration aims to reduce manual handoffs between in silico design and lab validation, enabling teams to generate biological data faster and prioritize the most promising candidates more efficiently as part of GenScript's broader AI Drug Discovery (AIDD) platform.
Sources:
GenScript and Tamarind Bio Partner to Connect AI ...
Tamarind Bio: AI Infrastructure for Biotech R&D
AI Drug Discovery (AIDD) Solutions
GenScript and Tamarind Bio: Partner to Connect AI Molecular ...
GenScript is Scripting Possibilities in AI-Driven Drug Discovery as ...
Tamarind Bio Partners with A-Alpha Bio to Streamline ...
BoltzGen - Tamarind Documentation
Introducing the Tamarind Bio Assay Portal
Introducing AI Protein Design Copilot by Tamarind Bio
Tamarind Bio Secures $13.6M Series A to Make AI More ...
Tamarind Bio: AI Inference Platform for Drug Discovery
Boltz Mol-1 Online | Small Molecule Discovery at ...
GenScript - Scripting Possibilities - The leader in molecular ...
GenScript and Mimulus Partner to Industrialize DNA-Based Data Storage for the AI Era